SERUR : Etude sérologique COVID-19 (Anti-SARS CoV 2) du Personnel de l'Université de Reims Champagne-Ardenne
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 389
- 试验地点
- 1
- 主要终点
- Prevalence of IgG and IgM anti-SARS CoV2 antibodies
研究概览
简要总结
This study was designed to determine, in a screening situation within the framework of university preventive medicine, the prevalence of positive anti-SARS-Cov 2 serology among the staff of the University of Reims Champagne-Ardenne. The serological tests chosen will allow systematic detection of anti-SARS-CoV-2 IgM and anti-SARS-Cov-2 IgG to assess the moment of potential contamination prior to resumption of occupational activity.
详细描述
Objective:
This study was designed to determine, in a screening situation within the framework of university preventive medicine, the prevalence of positive anti-SARS-Cov 2 serology among the staff of the University of Reims Champagne-Ardenne. The serological tests chosen will allow systematic detection of anti-SARS-CoV-2 IgM and anti-SARS-Cov-2 IgG to assess the moment of potential contamination prior to resumption of occupational activity.
Type of study:
This is a prevalence study, a single-center cross-sectional study published on the human person.
Population:
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Major volunteers from the Staff of the University of Reims Champagne-Ardenne (>18 years old)
排除标准
- •(Non Inclusion):
- •persons who do not desire to participate
结局指标
主要结局
Prevalence of IgG and IgM anti-SARS CoV2 antibodies
时间窗: Inclusion time was ½ day, time for blood sampling
Anti-SARS-Cov2 seroprevalence measured in blood sample collected at Day 0.
次要结局
未报告次要终点